Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Immumap Services ApS
APS
Bankrupt
Advertising protection
CVR 38169866
Agern Alle 3, 2970
Hørsholm
Forskning og eksperimentel udvikling indenfor bioteknologi
·
NACE 721100
Est. 2016 · 9 years old
3 employees
Monitor
Share
Denmark
/
Companies
/
Forskning og eksperimentel udvikling indenfor bioteknologi
/
Immumap Services ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
1M
1M
1M
0M
0M
0M
2017
1M
+100%
2018
1M
0%
2019
1M
0%
2020
EBITDA
DKK millions
0M
0M
-1M
-1M
-1M
-1M
2017
0M
+100%
2018
-1M
-100%
2019
-1M
0%
2020
Income statement
DKK thousands
Item
2017
2018
2019
2020
Gross profit
-318
1.402
674
521
Staff expenses
-904
-1.299
-1.582
-1.623
EBITDA
-1.222
103
-908
-1.102
Depreciation & amort.
-0
-0
-0
-0
EBIT
-1.222
103
-908
-1.102
Net financials
-51
-106
-128
-179
Profit before tax
-1.273
-3
-1.037
-1.282
Tax
-26
-0
-0
-0
Net profit
-1.247
-3
-1.037
-1.282
Balance sheet
DKK thousands
Item
2017
2018
2019
2020
Total assets
256
1.006
575
363
Equity
-1.197
-1.200
-2.237
-3.519
Long-term debt
1.251
1.957
2.562
3.375
Short-term debt
202
250
250
506
Total debt
1.453
2.207
2.812
3.881
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-211.6%
This company
2017
2020
Equity ratio
-970.3%
This company
38.2%
Market median
2640% below market
2017
2020
Return on equity
-128156200.0%
This company
18.4%
Market median
696501187% below market
2017
2020
Net profit margin (of gross profit)
-246.0%
This company
2017
2020
Asset turnover (of gross profit)
1.44×
This company
2017
2020
Debt / equity
1.10×
This company
0.62×
Market median
77% above market
2017
2020
Annual reports & filings
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
View
PDF
Annual report 2017
Filed via CVR / Virk · Period 2016-11-01 – 2017-12-31
View
PDF
More on Immumap Services ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
